The plenary program begins Saturday evening, April 15, with a session dedicated to targeting KRAS that will be chaired by Dafna Bar-Sagi, PhD, followed by the Opening Plenary Session on Sunday, April 16, chaired by Robert H. Vonderheide, MD, DPhil.

Beginning Monday morning, April 17, four diverse plenary sessions will examine several critical aspects of cancer research, from early detection and interception to new concepts in drug discovery and engineering. In this article, chairs of the four plenary sessions provide a preview of each session.

A record number of proffered abstracts led to an impressive set of clinical trial sessions at this year’s meeting, according to Annual Meeting Clinical Trials Committee Co-chairs Timothy A. Yap, MD, PhD, and Shivaani Kummar, MD. Highlights include four dedicated plenary sessions and three clinical trials minisymposia.

AACR Scientist↔Survivor Program Chair Anna D. Barker, PhD, FAACR, never imagined how successful the program would become when she founded it in 1998.

AACR’s journal on cancer immunology celebrates its 10th anniversary with a collection of top-cited articles that have been part of the growing and evolving field of research.